Zusammenfassung
Histopathologisch ist die Abgrezung eines Nebennierenrindentumors von einem Phäochromozytom am ehesten durch den Nachweis einer negativen Chromogranin A-Färbung möglich.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Clemmesen J (1965) Statistical studies in the aetiology of malignant neoplasma. II Munksgaard, Copenhagen. Danish Cancer Registry under National Anti-Cancer League
Bradley L III (1975) Primary and adjunctive therapy in carcinoma of the adrenal cortex. Surg Gynecol Obstet 141: 507
Luton JP, Cerdas S, Billaud L et al. (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy 322 (17): 195 —1201
Yano T, Linehan M, Anglard T et al. (1989) Genetic changes in human adrenocortical carcinomas. J N C I 81 (7): 518–523
Cibas E, Medeiros J, Weinberg D et al. (1990) Cellular DNA Profiles of Benign and Malignant Adrenocortical Tumors 14 (10) :948–955
Macfarlane D (1958) Cancer of the adrenal cortex. The natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 23: 155–185
Gröndal S, Eriksson B, Hagenäs L et al. (1990) Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. Acta Endorinol (Copenh) 122: 656–663
Bodie B, Novick A, Pontes E et al. (1989) The Cleveland Clinic experience with adrenal cortical carcinoma. J of Urol 141: 257–260
Thompson NW (1983) Adrenocortical carcinomas. In: Thompson NW, Vinik AI, (eds) Endocrine Surgery Update, Grane and Stratton, New York
Schteingardt DE, Motazedi A, Noonan RA, Thompson NW (1982) Treatment of adrenal carcinomas. Arch Surg 117: 1142–1146
Lubitz JA, Freeman L, Okun R. Mitotane ause in inoperable adrenal cortical carcinoma. JAMA 223: 1109–1112
Eriksson B, Öberg K, Curstedt T et al. (1987) Treatment of hormone-producing adrenocortical cancer with o.p’DDD and streptozocin 59 (8): 1398–1403
Flack MR, Pyle RG, Mullen NM et al. (1993) Oral gossypol in the treatment of metastatic adrenal cancer. J Clin Endocrinol Metab 76: 1019–1024
Stein LA, La Rocca R, Thomas R et al. (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncology 7 (4): 499–508
van Slooten H, Moolenar AJ, van Seters AP, Smeenk F (1984) The treatment of adrenocortical carcinoma with o.p’DDD: prognostic simplications of serum level monitoring Eur J Cancer Clin Oncol 20 (11): 47–53
Tattersall MHN, Lander H, Bain B et al. (1980) Cis-platinum treatment of metastatic adrenal carcinoma. Med J Aust 1: 419–421
Haq M, Legha S, Samaan N et al. (1980) Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep 64: 909–913
van Slooten H, van Oosterom AT (1983) CAP (Cyclophosphamide, Doxorubicin and Cisplatin) Regimen in Adrenal Cortical Carcinoma. Cancer Treat Rep 67 (4): 377–379
Johnson D, Greco A (1986) Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16) Cancer 58: 2198–2202
Crocket P, Clark ACL (1989) Combination chemotherapy for adrenal carcinoma: response in a 51/2-year-old male. Medical and Pediatric Oncology 17: 62–65
Schlumberger M, Brugierers L, Gicquel C et al. (1991) 5-Fluorouracil, doxorubine and cisplatin as treatment for adrenal cortical carcinoma. Cancer 67: 2997–3000
Page DL, DeLellis RA, Hough AJ (1986) Tumors of the adrenal. In: Atlas of Tumor Pathology, Washington DC, AFIP
Manager WM, Gifford RW Jr, Hoffman BB (1985) Pheochromocytoma a clinical and experimental overview. Curr Probl Cancer 9: 1
Irvin GL, Fishman LM, Sher JA (1983) Familial pheochromocytoma. Surgery 94: 938
Cryer PE (1985) Pheochromocytoma. Clin Endocrinol Metab 14: 203
Lewis PD (1971) A cytophotometric study of benign and malignant pheochromocytomas. Virchows Arch 9: 371
Medeiros LJ, Wolf BC, Balogh K et al. (1985) Adreanl pheochromocytoma a clinicopathologic review of 60 cases. Hum Pathol 16: 580
van Heerden JA, Sheps SG, Hamberger B et al. (1982) Pheochromocytoma: current status and changing trends. Surgery 91: 367
Bravo EL, Gifford RW Jr (1984) Pheochromocytoma diagnosis, localisation and management. N Engl J Med 311: 1298–1303
Modlin IM, Farndon JR, Shepherd A et al. (1979) Pheochromocytoma in 72 patients: clinial and diagnostic features, treatment and long term results. Br J Surg 66: 456–465
Sheedy PE II, Hattery RR, Stephens DH et al. (1983) Computed tomography of the adrenal gland. In: Hagga JR, Alfidi FJ (eds) Computed Tomography of the whole Body, Vol 2 St Louis C.V. Mosby 681–697
Reinig JW, Doppman JL (1986) Magnetic resonance imaging of the adrenal. Radiologe 26: 186
Shapiro B, Copp JE, Sisson JC et al. (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26: 576
Ross EJ, Richard BNC, Kaufmann L et al. (1969) Preoperative and operative management of patients with pheochromocytoma: Anesth Ana1g Reanimatol 59: 154–162
Shapiro B, Sisson JC, Wieland DM (1991) Radiopharmaceutical therapy of malignant pheochromocytoma with I131 metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 35: 269–276
Lumbroso J, Schlumberger M, Tenenbaum F et al. (1991) I131-metaiodobenzylguanidine therapy in 10 patients with malignant pheochromocytoma. J Nucl Biol Med 35: 288–291
Krempf F, Lumbroso J, Mornex R et al. (1991) Treatment of malignant pheochromocytoma with I131 metaidobenzylguanidine: a French multicenter study. J Nucl Biol Med 35: 284–287
Troncone L, Ruffini V, Daidone MS et al. (1991) I131-metaidobenzylguanidine treatment of malignant pheochromocytoma: experience of the Roma group
Keiser H, Goldstein DS, Wade JL et al. (1985) Treatment of malignant pheochromocytoma with combination chemotherapy: Hypertension I-18–24
Averbuch SD, Steakley CR, Young RC et al. (1988) Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, Vincristine and Dacarbazine. Ann Int Med 109: 267–273
Feldman JM (1983) Treatment of metastatic pheochromocytoma with streptozocin. Arch Int Med 143: 1799–1800
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Eriksson, B., Öberg, K. (1995). Nebennierentumoren. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_29
Download citation
DOI: https://doi.org/10.1007/978-3-662-10494-1_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58586-2
Online ISBN: 978-3-662-10494-1
eBook Packages: Springer Book Archive